Idexx Laboratories IDXX
NASDAQ IDXX
$676.04 +5.33 (+0.79%)
At close: Nov 6, 2026 · 4:00 PM EST

Idexx Laboratories (IDXX) Amortization of Deferred Charges (2015 - 2016)

Updated

Analysis

Idexx Laboratories (IDXX) Amortization of Deferred Charges (2015 - 2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn
10 Idexx Laboratories 53.33 Bn 52.56 Bn 764.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 116,000.00
Dec 31, 2015 465,000.00
Mar 31, 2015 91,000.00
API Access

Idexx Laboratories Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=IDXX&period=max&api_key=YOUR_API_KEY